MDWD - MediWound burn therapy NexoBrid launched in US
2023-09-21 14:15:44 ET
More on MediWound
- Seeking Alpha’s Quant Rating on MediWound
- Financial information for MediWound
- MediWound Ltd. (MDWD) Q2 2023 Earnings Call Transcript
- MediWound GAAP EPS of $0.10 beats by $0.47, revenue of $4.77M beats by $0.59M
- MediWound gains on positive advice from EMA on phase 3 trial for EscharEx
For further details see:
MediWound burn therapy NexoBrid launched in US